Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Patient Preference and Adherence|June 13, 2014
Patient adherence issues in the treatment of hepatitis CDominique Larrey, Marie-Pierre Ripault, Georges-Philippe Pageaux
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
The current status of antiviral therapy of chronic hepatitis BTarik Asselah, Marie-Pierre Ripault, Corinne Castelnau, et al.
World Journal of Gastroenterology|June 28, 2012
Impact of ribavirin dose on retreatment of chronic hepatitis C patientsChristiane Stern, Michelle Martinot-Peignoux, Marie Pierre Ripault, et al.
The Annals of Pharmacotherapy|November 22, 2013
Acute hepatitis and renal failure related to intranasal buprenorphine misuse: case report and analysis of cases reported to the French network for drug monitoringCéline Eiden, Marie-Pierre Ripault, Dominique Larrey, et al.
Emerging Infectious Diseases|November 1, 2006
Eighth major clade for hepatitis delta virusFrédéric Le Gal, Elyanne Gault, Marie-Pierre Ripault, et al.
Gastroenterology|June 10, 2006
Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirinValérie Paradis, Tarik Asselah, Delphine Dargere, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 30, 2011
Prospective evaluation of the management of hepatocellular carcinoma in the elderlyViolaine Ozenne, Mohamed Bouattour, Nathalie Goutté, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 6, 2013
Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNAMichelle Martinot-Peignoux, Martine Lapalus, Cédric Laouénan, et al.
Hepatology (Baltimore, Md.)|August 31, 2006
Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-upCorinne Castelnau, Frédéric Le Gal, Marie-Pierre Ripault, et al.
Antiviral Therapy|December 25, 2009
Influence of genotype on hepatitis B surface antigen kinetics in hepatitis B e antigen-negative patients treated with pegylated interferon-alpha2aRami Moucari, Michelle Martinot-Peignoux, Vincent Mackiewicz, et al.
Pageof 3